Wolfson Institute of Preventive Medicine

Search - ZOO
Search - K2
Search - Categories
Search - Contacts
Search - Content
Search - Newsfeeds
Search - Weblinks

Johannes Michiel Luteijn, BSc (Groningen), MSc (Groningen), PhD (Ulster)

Post Doctoral Research Assistant

Centre for Environmental and Preventive Medicine
email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Tel: +44 (0) 20 7882 6286


I joined the Wolfson Institute of Preventive Medicine in September 2013 and next to my part-time position at QMUL (0.5 FTE), I am scientific coordinator at the EUROmediCAT project on drug safety in pregnancy (0.5 FTE, based at University of Ulster).


I became involved in quantitative medicine in 2008 during my MSc at the University of Groningen during which I analysed the health economics of MRSA screening in cooperation with BaseCase GmbH. After this project, I continued my cooperation with BaseCase via the BOTUSA project on health economics of chest x-ray screening in HIV positive individuals in Botswana. In 2009, I became involved in epidemiology and health policy when I performed evaluation of the pregnancy prevention programs of teratogenic drugs at the Dutch Medicines Evaluation Board (CBG-MEB). Following successful completion of my MSc in Groningen, I pursued a PhD at the European Surveillance Surveillance of Congenital Anomalies (EUROCAT), headquartered at the University of Ulster. During my PhD project, I lead the EUROCAT surveillance response to the 2009 H1N1 influenza pandemic. This surveillance response included a pandemic vaccination policy survey in cooperation with the European Medicines Agenda (EMA), systematic review and a number of epidemiological studies related to 2009 H1N1 pandemic influenza and congenital anomalies.

2013: Wolfson and EUROmediCAT

After obtaining my PhD in May 2013, I was appointed scientific coordinator of the FP7-project EUROmediCAT. EUROmediCAT aims to develop a European reproductive pharmacovigilance system by combining EUROCAT data with data of existing healthcare databases. My work at the Wolfson involves development of signal detection software for EUROmediCAT and I am working on this together with Professor Joan Morris. Due to the large amount of congenital anomaly-drug combinations, emphasis is placed on multiple testing procedures.

Return to top